시장보고서

상품코드

1586367

디지털 치료 시장 규모, 점유율, 동향, 산업 분석 보고서 : 수익 모델별, 용도별, 최종사용자별, 지역별 - 시장 예측(2024-2032년)

Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model, Application, End Users, and Region - Market Forecast, 2024-2032

발행일: 2024년 10월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 116 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 디지털 치료 시장 규모는 2032년까지 706억 3,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

디지털 치료 시장의 성장은 선진국뿐만 아니라 신흥국 시장에서도 전 세계적으로 인터넷 접속이 증가하고 있는 것이 원동력이 되고 있습니다. 예를 들어, Our World in Data의 통계에 따르면, 2000년 아시아 인구의 7%가 인터넷에 접속할 수 있는 반면, 아프리카 지역에서는 3%에 불과했지만, 2016년에는 인터넷에 접속할 수 있는 인구의 비율이 크게 증가하여 한국과 일본에서는 인구의 91%, 덴마크와 노르웨이에서는 인구의 97%가 인터넷에 접속할 수 있는 것으로 나타났습니다. 덴마크와 노르웨이에서는 인구의 97%가 인터넷에 접속할 수 있으며, 6년 후인 2022년에는 아프리카의 주요 지역에서 81%의 인구가 인터넷에 접속할 수 있을 것으로 예상됩니다.

전체 생태계를 디지털화하기 위한 정부의 노력과 인센티브는 예측 기간 동안 디지털 치료 시장을 촉진할 것으로 예상됩니다. 헬스케어 부문의 정부 자금 증가와 헬스케어 부문의 디지털화를 위한 제도 도입은 연구 기간 동안 디지털 치료 시장을 촉진할 것으로 예상됩니다. 예를 들어, 2023년 8월 인도 정부는 Ayushman Bharat Digital Mission(ABDM)에 따라 디지털 건강 인센티브 제도(DHIS)를 도입하여 디지털 건강, 연구소 및 의료 기술 기업의 채택을 장려했습니다. 디지털 헬스 인센티브 제도는 새로운 헬스 테크 스타트업에 최대 4조 루피의 인센티브를 제공합니다.

디지털 치료 서비스의 주요 소비자는 고용주와 환자입니다. 주요 기업들은 직원용 패키지에 치료 서비스를 추가해 생활습관 관리, 우울증, 고혈압 관련 서비스를 제공하기 시작했습니다. 당뇨병, 심혈관질환 등 만성질환을 앓고 있는 환자들은 일상적인 상담을 위해 서비스를 이용할 수 있습니다.

디지털 치료 시장 보고서 하이라이트

수익 모델 분석에 따르면, 구독 부문은 세계 시장에서 상당한 성장을 이룰 것으로 예상됩니다. 이러한 성장은 구독 기반 수익 모델과 관련된 주요 이점에 기인합니다.

최종사용자별 분석에 따르면, 2024년부터 2032년까지 고용주 부문은 세계 주요 기업들이 디지털 치료 패키지 서비스를 시작함에 따라 고용주 부문이 시장을 장악할 것으로 예상됩니다.

2023년, 북미는 인터넷에 접속할 수 있는 인구 비율이 높고 디지털화가 진행되면서 디지털 치료 시장을 독점하고 있습니다.

인도 디지털 치료 시장은 헬스케어 분야의 디지털화를 위한 규제 지원과 이니셔티브에 힘입어 큰 폭의 성장이 예상됩니다.

주요 시장 기업으로는 Proteus Digital Health, Inc, Livongo Health, Inc., Voluntis Inc., Resmed, Inc., Welldoc, Inc., 2Morrow Inc.

시장 현황
디지털 치료 시장 역학
- 성장 촉진요인과 기회
  - 서비스 지향 소프트웨어의 진보가 시장 성장을 견인
  - 인터넷에 소비하는 매일의 시간 증가가 시장 규모를 증진시키고 있다
- 성장 억제요인과 과제
  - 자본 투자의 부족
PESTEL 분석
디지털 치료 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 디지털 치료 시장 : 수익 모델별

주요 조사 결과
소개
구독
가치 기반
1회 한정 구입

제6장 세계의 디지털 치료 시장 : 용도별

주요 조사 결과
소개
당뇨병
비만
뇌혈관 장애(CVD)
중추 신경 질환
호흡기질환
금연
라이프스타일 관리
예방용
기타

제7장 세계의 디지털 치료 시장 : 최종사용자별

주요 조사 결과
소개
환자
프로바이더
지불자
고용주
기타

제8장 세계의 디지털 치료 시장 : 지역별

주요 조사 결과
소개
- 디지털 치료 시장 평가 : 지역별, 2019-2032년
북미
- 북미 : 수익 모델별, 2019-2032년
- 북미 : 용도별, 2019-2032년
- 북미 : 최종사용자별, 2019-2032년
- 미국
- 캐나다
유럽
- 유럽 : 수익 모델별, 2019-2032년
- 유럽 : 용도별, 2019-2032년
- 유럽 : 최종사용자별, 2019-2032년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 수익 모델별, 2019-2032년
- 아시아태평양 : 용도별, 2019-2032년
- 아시아태평양 : 최종사용자별, 2019-2032년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 수익 모델별, 2019-2032년
- 중동 및 아프리카 : 용도별, 2019-2032년
- 중동 및 아프리카 : 최종사용자별, 2019-2032년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 수익 모델별, 2019-2032년
- 라틴아메리카 : 용도별, 2019-2032년
- 라틴아메리카 : 최종사용자별, 2019-2032년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제9장 경쟁 상황

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제10장 기업 개요

Proteus Digital Health, Inc.
Fitbit Inc.
Pear Therapeutics, Inc.
Kaia Health
Happify, Inc.
Medtronic Plc.
Omada Health, Inc.
Livongo Health, Inc.
Voluntis, Inc.
Resmed, Inc.
Welldoc, Inc.
2Morrow Inc.
Canary Health
Mindable Health GmbH.

ksm 24.11.19

The digital therapeutics market size is expected to reach USD 70.63 billion by 2032, according to a new study by Polaris Market Research. The report "Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model (Subscription and Value-Based), Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The digital therapeutics market growth is driven by increasing internet access globally in developed as well as developing countries. For instance, according to statistics of Our World in Data, in 2000, 7% of the Asian population had access to the internet, while just 3% of the African region was online. By 2016, the population share with internet access increased significantly, with 91% of the population in South Korea and Japan having internet access and 97% of the population in Denmark and Norway online. After six years, in 2022, major regions of Africa witnessed 81% of the population share gain internet access.

Government initiatives and incentives in order to digitalize the whole ecosystem are anticipated to boost the digital therapeutics market during the forecast years. Increased government funding in the healthcare sector and the introduction of schemes for the digitalization of the healthcare sector are expected to fuel the digital therapeutics market during the study time. For instance, in August 2023, the government of India introduced the Digital Health Incentive Scheme (DHIS) under the Ayushman Bharat Digital Mission (ABDM) to encourage the adoption of digital health, laboratories, and health tech companies. In the digital health incentive scheme, new health tech startups will be offered incentives up to 4 crore INR.

Employers and patients are the major consumers of digital therapeutic services. Major companies have started adding therapies as services in their employee packages, providing lifestyle management, depression, and hypertension-related services. Patients with chronic diseases, such as diabetes and cardiovascular diseases, can use the services for day-to-day consultation.

Digital Therapeutics Market Report Highlights

By revenue model analysis, the subscription segment is anticipated to experience substantial growth in the global market. This growth is attributed to major advantages that are associated with the subscription-based revenue model.

By end users analysis, the employers segment is anticipated to dominate the market from 2024 to 2032 due to major companies globally having started including digital therapeutics packages in their services.

In 2023, North America dominated the digital therapeutics market due to the large share of the population having internet access and increasing digitalization.

The digital therapeutics market in India is projected for substantial growth due to the regulatory support and initiatives for the digitalization of the healthcare sector.

The key market players are Proteus Digital Health, Inc.; Fitbit, Inc.; Pear Therapeutics, Inc.; Kaia Health; Happify, Inc.; Medtronic Plc.; Omada Health, Inc.; Livongo Health, Inc.; Voluntis Inc.; Resmed, Inc.; Welldoc, Inc.; 2Morrow Inc.; Canary Health; and Mindable Health GmbH.

Polaris Market Research has segmented the digital therapeutics market report based on revenue model, application, end users, and region:

By Revenue Model Outlook (Revenue - USD billion, 2019-2032)

Subscription
Value-based
One Time Purchase

By Application Outlook (Revenue - USD billion, 2019-2032)

Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Lifestyle Management
Preventive Applications
Others

By End Users Outlook (Revenue - USD billion, 2019-2032)

Patients
Providers
Payers
Employers
Others

By Regional Outlook (Revenue - USD billion, 2019-2032)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of the Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Digital Therapeutics Market Insights

4.1. Digital Therapeutics Market - Market Snapshot
4.2. Digital Therapeutics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Advancements in Service Oriented Software Are Driving Market Growth
  - 4.2.1.2. Increase in Daily Hours Spend on Internet is Propelling Market Size
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of Capital Investment
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Digital Therapeutics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Digital Therapeutics Market, by Revenue Model

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
5.3. Subscription
- 5.3.1. Global Digital Therapeutics Market, by Subscription, by Region, 2019-2032 (USD billion)
5.4. Value Based
- 5.4.1. Global Digital Therapeutics Market, by Value Based, by Region, 2019-2032 (USD billion)
5.5. One Time Purchase
- 5.5.1. Global Digital Therapeutics Market, by One Time Purchase, by Region, 2019-2032 (USD billion)

6. Global Digital Therapeutics Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
6.3. Diabetes
- 6.3.1. Global Digital Therapeutics Market, by Diabetes, by Region, 2019-2032 (USD billion)
6.4. Obesity
- 6.4.1. Global Digital Therapeutics Market, by Obesity, by Region, 2019-2032 (USD billion)
6.5. CVD
- 6.5.1. Global Digital Therapeutics Market, by CVD, by Region, 2019-2032 (USD billion)
6.6. CNS Disease
- 6.6.1. Global Digital Therapeutics Market, by CNS Disease, by Region, 2019-2032 (USD billion)
6.7. Respiratory Disease
- 6.7.1. Global Digital Therapeutics Market, by CVD, by Respiratory Disease, 2019-2032 (USD billion)
6.8. Smoking Cessation
- 6.8.1. Global Digital Therapeutics Market, by Smoking Cessation, by Region, 2019-2032 (USD billion)
6.9. Lifestyle Management
- 6.9.1. Global Digital Therapeutics Market, by Lifestyle Management, by Region, 2019-2032 (USD billion)
6.10. Preventive Applications
- 6.10.1. Global Digital Therapeutics Market, by Preventive Applications, by Region, 2019-2032 (USD billion)
6.11. Others
- 6.11.1. Global Digital Therapeutics Market, by Others, by Region, 2019-2032 (USD billion)

7. Global Digital Therapeutics Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
7.3. Patients
- 7.3.1. Global Digital Therapeutics Market, by Patients, by Region, 2019-2032 (USD billion)
  - 7.3.1.1.
7.4. Providers
- 7.4.1. Global Digital Therapeutics Market, by Providers, by Region, 2019-2032 (USD billion)
7.5. Payers
- 7.5.1. Global Digital Therapeutics Market, by Payers, by Region, 2019-2032 (USD billion)
7.6. Employers

Global Digital Therapeutics Market, by Employers, by Region, 2019-2032 (USD billion)

7.7. Others

Global Digital Therapeutics Market, by Others, by Region, 2019-2032 (USD billion)

8. Global Digital Therapeutics Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Digital Therapeutics Market Assessment, By Geography, 2019-2032 (USD billion)
8.3. Digital Therapeutics Market - North America
- 8.3.1. North America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
- 8.3.2. North America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
- 8.3.3. North America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.3.4. Digital Therapeutics Market - U.S.
  - 8.3.4.1. U.S.: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.3.4.2. U.S.: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.3.4.3. U.S.: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.3.5. Digital Therapeutics Market - Canada
  - 8.3.5.1. Canada: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.3.5.2. Canada: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.3.5.3. Canada: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
8.4. Digital Therapeutics Market - Europe
- 8.4.1. Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
- 8.4.2. Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
- 8.4.3. Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.4. Digital Therapeutics Market - UK
  - 8.4.4.1. UK: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.4.2. UK: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.4.3. UK: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.5. Digital Therapeutics Market - France
  - 8.4.5.1. France: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.5.2. France: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.5.3. France: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.6. Digital Therapeutics Market - Germany
  - 8.4.6.1. Germany: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.6.2. Germany: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.6.3. Germany: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.7. Digital Therapeutics Market - Italy
  - 8.4.7.1. Italy: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.7.2. Italy: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.7.3. Italy: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.8. Digital Therapeutics Market - Spain
  - 8.4.8.1. Spain: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.8.2. Spain: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.8.3. Spain: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.9. Digital Therapeutics Market - Netherlands
  - 8.4.9.1. Netherlands: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.9.2. Netherlands: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.9.3. Netherlands: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.10. Digital Therapeutics Market - Russia
  - 8.4.10.1. Russia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.10.2. Russia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.10.3. Russia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.4.11. Digital Therapeutics Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.4.11.2. Rest of Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.4.11.3. Rest of Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
8.5. Digital Therapeutics Market - Asia Pacific
- 8.5.1. Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
- 8.5.2. Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
- 8.5.3. Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.4. Digital Therapeutics Market - China
  - 8.5.4.1. China: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.4.2. China: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.4.3. China: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.5. Digital Therapeutics Market - India
  - 8.5.5.1. India: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.5.2. India: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.5.3. India: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.6. Digital Therapeutics Market - Malaysia
  - 8.5.6.1. Malaysia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.6.2. Malaysia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.6.3. Malaysia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.7. Digital Therapeutics Market - Japan
  - 8.5.7.1. Japan: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.7.2. Japan: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.7.3. Japan: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.8. Digital Therapeutics Market - Indonesia
  - 8.5.8.1. Indonesia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.8.2. Indonesia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.8.3. Indonesia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.9. Digital Therapeutics Market - South Korea
  - 8.5.9.1. South Korea: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.9.2. South Korea: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.9.3. South Korea: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.10. Digital Therapeutics Market - Australia
  - 8.5.10.1. Australia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.10.2. Australia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.10.3. Australia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.5.11. Digital Therapeutics Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.5.11.2. Rest of Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.5.11.3. Rest of Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
8.6. Digital Therapeutics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
- 8.6.2. Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
- 8.6.3. Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.6.4. Digital Therapeutics Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.6.4.2. Saudi Arabia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.6.4.3. Saudi Arabia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.6.5. Digital Therapeutics Market - UAE
  - 8.6.5.1. UAE: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.6.5.2. UAE: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.6.5.3. UAE: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.6.6. Digital Therapeutics Market - Israel
  - 8.6.6.1. Israel: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.6.6.2. Israel: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.6.6.3. Israel: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.6.7. Digital Therapeutics Market - South Africa
  - 8.6.7.1. South Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.6.7.2. South Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.6.7.3. South Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.6.8. Digital Therapeutics Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.6.8.2. Rest of Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.6.8.3. Rest of Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
8.7. Digital Therapeutics Market - Latin America
- 8.7.1. Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
- 8.7.2. Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
- 8.7.3. Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.7.4. Digital Therapeutics Market - Mexico
  - 8.7.4.1. Mexico: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.7.4.2. Mexico: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.7.4.3. Mexico: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.7.5. Digital Therapeutics Market - Brazil
  - 8.7.5.1. Brazil: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.7.5.2. Brazil: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.7.5.3. Brazil: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.7.6. Digital Therapeutics Market - Argentina
  - 8.7.6.1. Argentina: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.7.6.2. Argentina: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.7.6.3. Argentina: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
- 8.7.7. Digital Therapeutics Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  - 8.7.7.2. Rest of Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  - 8.7.7.3. Rest of Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Proteus Digital Health, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Fitbit Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Pear Therapeutics, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Kaia Health
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Happify, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Medtronic Plc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Omada Health, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Livongo Health, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Voluntis, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Resmed, Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Welldoc, Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. 2Morrow Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Canary Health
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Mindable Health GmbH.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development